Determining the cost-effectiveness of preventing cardiovascular disease: Are estimates calculated over the duration of a clinical trial adequate?
Steven A. Grover, Louis Coupal, Ilka LowensteynVolume:
24
Year:
2008
Language:
french
DOI:
10.1016/s0828-282x(08)70174-0
File:
PDF, 172 KB
french, 2008